10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 610,785 | 618,727 | 516,409 | 490,490 | 298,845 |
| Cost of Goods | 196,303 | 209,414 | 120,386 | 74,091 | 58,468 |
| Gross Profit | 414,482 | 409,313 | 396,023 | 416,399 | 240,377 |
| Operating Expenses | 609,344 | 675,056 | 564,353 | 468,743 | 774,987 |
| Operating Income | -194,559 | -265,329 | -167,944 | -52,253 | -534,142 |
| Interest Expense | 4 | 33 | 476 | 866 | 1,682 |
| Other Income | 16,863 | 16,599 | 6,449 | -596 | 1,348 |
| Pre-tax Income | -177,700 | -248,763 | -161,971 | -53,715 | -534,476 |
| Income Tax | 4,927 | 6,336 | 4,029 | 4,508 | 8,255 |
| Net Income Continuous | -182,627 | -255,099 | -166,000 | -58,223 | -542,731 |
| Net Income | $-182,627 | $-255,099 | $-166,000 | $-58,223 | $-542,731 |
| EPS Basic Total Ops | -1.52 | -2.18 | -1.46 | -0.53 | -5.37 |
| EPS Basic Continuous Ops | -1.52 | -2.18 | -1.46 | -0.53 | -5.37 |
| EPS Diluted Total Ops | -1.52 | -2.18 | -1.46 | -0.53 | -5.37 |
| EPS Diluted Continuous Ops | -1.52 | -2.18 | -1.46 | -0.53 | -5.37 |
| EPS Diluted Before Non-Recurring Items | -1.52 | -1.66 | -1.46 | -0.53 | -0.95 |
| EBITDA(a) | $-150,851 | $-221,710 | $-134,938 | $-23,999 | $-515,121 |